PortfoliosLab logo

AnaptysBio, Inc. (ANAB)

Equity · Currency in USD · Last updated Dec 9, 2022

Company Info

ISINUS0327241065
CUSIP032724106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$28.21
Year Range$18.71 - $37.07
EMA (50)$27.60
EMA (200)$27.06
Average Volume$189.88K
Market Capitalization$798.93M

ANABShare Price Chart


Loading data...

ANABPerformance

The chart shows the growth of $10,000 invested in AnaptysBio, Inc. in Jan 2017 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $16,594 for a total return of roughly 65.94%. All prices are adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
32.13%
5.71%
ANAB (AnaptysBio, Inc.)
Benchmark (^GSPC)

ANABCompare to other instruments

Search for stocks, ETFs, and funds to compare with ANAB

ANABReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-3.03%4.12%
6M17.79%-3.70%
YTD-18.82%-16.84%
1Y-9.21%-15.43%
5Y-20.35%8.39%
10Y9.02%9.75%

ANABMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-8.00%-4.38%-19.07%-5.42%-18.85%6.90%3.15%10.89%9.86%13.09%-4.23%2.10%
202120.56%10.73%-24.91%8.35%2.23%8.63%-11.38%11.44%5.90%21.31%-1.67%7.42%
2020-10.65%2.96%-5.48%10.54%22.15%17.09%-19.61%-3.51%-14.89%99.73%-12.46%-16.63%
20193.97%3.84%6.07%-0.45%0.12%-22.51%-4.80%-24.32%-13.92%7.80%-64.24%20.46%
20184.64%16.48%-15.22%-9.90%-17.04%-8.69%10.25%13.18%12.56%-25.11%-0.19%-14.47%
2017-0.29%40.71%16.35%-3.86%-4.09%-6.49%1.67%14.96%24.96%88.93%27.29%19.83%

ANABSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current AnaptysBio, Inc. Sharpe ratio is -0.17. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.20JulyAugustSeptemberOctoberNovemberDecember
-0.17
-0.65
ANAB (AnaptysBio, Inc.)
Benchmark (^GSPC)

ANABDividend History


AnaptysBio, Inc. doesn't pay dividends

ANABDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-78.06%
-17.37%
ANAB (AnaptysBio, Inc.)
Benchmark (^GSPC)

ANABWorst Drawdowns

The table below shows the maximum drawdowns of the AnaptysBio, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AnaptysBio, Inc. is 92.08%, recorded on Nov 8, 2019. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.08%Mar 5, 2018426Nov 8, 2019
-32.97%Mar 31, 201747Jun 7, 201732Jul 24, 201779
-32.31%Jul 25, 201716Aug 15, 201715Sep 6, 201731
-14.04%Jan 25, 20188Feb 5, 20187Feb 14, 201815
-10.4%Oct 13, 20174Oct 18, 201718Nov 13, 201722
-7.89%Feb 27, 20175Mar 3, 20176Mar 13, 201711
-5.75%Sep 19, 20176Sep 26, 20177Oct 5, 201713
-5.55%Feb 20, 20183Feb 22, 20186Mar 2, 20189
-5.19%Jan 30, 20173Feb 1, 20172Feb 3, 20175
-4.41%Feb 15, 20172Feb 16, 20171Feb 17, 20173

ANABVolatility Chart

Current AnaptysBio, Inc. volatility is 41.28%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%JulyAugustSeptemberOctoberNovemberDecember
41.28%
23.44%
ANAB (AnaptysBio, Inc.)
Benchmark (^GSPC)